Scientific Program
 
Scientific ProgramSearch Abstract
 
Session
 
Hodgkin Clinical
Date: Saturday, 06 June 2009
Time:08:00-09:15
Room:Hall 4/5
 
08:00-08:15
FINAL RESULTS OF THE HDR2 STUDY – A EUROPEAN MULTICENTER TRIAL IN PATIENTS WITH RELAPSED HODGKIN LYMPHOMA 0501
Engert, Andreas, Haverkamp, Heinz, Borchmann, Peter, Mueller, Horst, Diehl, Volker, Döhner, Hartmut, Metzner, Bernd, Franke, Astrid, Smardova, Lenka, Niederwieser, Dietger, Wilhelm, Martin, Goebeler, Maria-Elisabeth, Schmitz, Norbert, Sureda, Anna, Baars, Jooke, Raemaekers, John, Josting, Andreas (Cologne, Germany)
 
08:15-08:30
EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE ADVANCED-STAGE HODGKIN LYMPHOMA, IMPROVES THE OVERALL TREATMENT OUTCOME OF ABVD: A GITIL MULTICENTER CLINICAL STUDY 0502
Gallamini , Andrea , Fiore , Francesca , Sorasio, Roberto, Rambaldi, Alessandro , Patti, Caterina , Stelitano , Caterina , Viviani , Simonetta , Di Raimondo , Francesco , Feldman , Tatyana , Biggi , Alberto, Rossi , Andrea , Mistretta, Alessandro, Bonfante , Valeria , Chiarenza , Alessandra , Cantonetti , Maria , Gavarotti , Paolo , Tarella , Corrado (CUNEO, Italy)
 
08:30-08:45
ROBUST ANTITUMOR ACTIVITY OF THE ANTIBODY-DRUG CONJUGATE SGN-35 WHEN ADMINISTERED EVERY 3 WEEKS TO PATIENTS WITH RELAPSED OR REFRACTORY CD30 POSITIVE HEMATOLOGIC MALIGNANCIES IN A PHASE 1 STUDY 0503
Younes, Anas, Forero-Torres, Andres, Bartlett, Nancy L., Leonard, John P., Kennedy, Dana A., Sievers, Eric L. (Houston, United States of America)
 
08:45-09:00
PET-CT ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA. RESULTS IN 118 PATIENTS 0504
Pavlovsky, Santiago, Pavlovsky, Astrid, Fernandez, Isolda, Zoppegno, Lucia, Cerutti, Ider, Pavlovsky, Miguel Arturo, Prates, Maria Virginia, Basquiera, Ana, Corrado, Claudia, Milone, Gustavo, Cabrejo, Maria, Fernandez Grecco, Horacio, Avila, Graciela, Flores Dutrus, Viviana, Gumpel, Carina, Cabanne, Vanina, Saba, Silvia, Lastiri, Francisco (Buenos Aires, Argentina)
 
09:00-09:15
PANOBINOSTAT HAS ACTIVITY IN TREATMENT-REFRACTORY HODGKIN LYMPHOMA 0505
DeAngelo, Daniel, Spencer, Andrew, Ottmann, Oliver (P), Fischer, Thomas, Kindler, Thomas, Bhalla, Kapil, Liu, Angela, Parker, Kathryn, Rupani, Haren, Homji, Natasha, Ashton, Ed, Jalaluddin, Muhammad, Laird, Glen, Scott, Jeffrey, Prince, Miles (Boston, United States of America)